Form D/A CoastEdge Focus Fund
http://archive.fast-edgar.com/20240319/ABZ2222CZ222J2Z2222T22ZZOWNDJLGS7262
Filed on: March 19, 2024
Form 8-K COLUMBUS MCKINNON CORP For: Mar 18
http://archive.fast-edgar.com/20240319/AOLZW22C422262Z2222L22ZZMCLLZ2V22I62
Filed on: March 19, 2024
Form 4 CEVA INC For: Mar 15 Filed by: SILVER LOUIS
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 8-K Coya Therapeutics, Inc. For: Mar 19
0001835022false00018350222024-03-192024-03-19
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 19, 2024
Coya Therapeutics, Inc.
(Exact name of Registrant as Specified in Its Charter)
... (continue reading...)
Form D SoraFinance a Series of
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
More SEC Filings
View Older Stories-
Form 6-K Evaxion Biotech A/S For: Mar 19
-
Form 424B5 UNITEDHEALTH GROUP INC
-
Form D OPX2024 AI 03 a Series
-
Form 4 Chubb Ltd For: Mar 15 Filed by: Wayland Joseph F
-
Form D Nesh a Series of CGF2021
-
Form 6-K dLocal Ltd For: Mar 19
-
Form 8-K MICROSTRATEGY Inc For: Mar 19
-
Form D Tundra Angels Upwardli
-
Form 10-K Aterian, Inc. For: Dec 31
-
Form ARS S&P Global Inc. For: Dec 31
-
Form 144 PARK OHIO HOLDINGS CORP Filed by: WERT JAMES W
-
Form 8-K Crescent Energy Co For: Mar 19
-
Form DEFA14A Floor & Decor Holdings,
-
Form SC 13D/A Bally's Corp Filed by: Standard General L.P.
-
Form 8-K Tonix Pharmaceuticals For: Mar 19
-
Form 8-K Acumen Pharmaceuticals, For: Mar 19
-
Form 8-K MICROSTRATEGY Inc For: Mar 18
-
Form DEFA14A S&P Global Inc.
-
Form 8-K CERUS CORP For: Mar 19
-
Form 3 Northwest Bancshares, For: Mar 18 Filed by: Schosser Douglas M
-
Form DEFA14A FIRST UNITED CORP/MD/
-
Form DEF 14A Floor & Decor Holdings, For: May 08
-
Form DEF 14A S&P Global Inc. For: May 01
-
Form RW Thimble Point Acquisitio
-
Form 8-K ORAMED PHARMACEUTICALS For: Mar 14
-
Form 4 Purple Innovation, Inc. For: Mar 15 Filed by: DeMartini Robert
-
Form 8-K DELCATH SYSTEMS, INC. For: Mar 18
-
Form 6-K Nano Labs Ltd For: Mar 19
-
Form 4 Purple Innovation, Inc. For: Mar 15 Filed by: HAYNOR ERIC SCOTT
-
Form PREC14A MRC GLOBAL INC. Filed by: ENGINE CAPITAL, L.P.
-
Form 4 Purple Innovation, Inc. For: Mar 15 Filed by: HUTCHINGS JEFFREY LAYNE
-
Form 8-K TC BioPharm (Holdings) For: Mar 14
-
Form 8-A12B LOBO EV TECHNOLOGIES
-
Form 4 Nuvectis Pharma, Inc. For: Mar 18 Filed by: BENTSUR RON
-
Form D Nfinite Nanotechnology
-
Form DEF 14A FIRST UNITED CORP/MD/ For: May 09
-
Form F-3ASR Legend Biotech Corp
-
Form D Reflect Ventures (GoFlux
-
Form 4 STANLEY BLACK & DECKER, For: Mar 15 Filed by: Tan Irving
-
Form 4 STANLEY BLACK & DECKER, For: Mar 15 Filed by: Mitchell Adrian V
-
Form 4 STANLEY BLACK & DECKER, For: Mar 15 Filed by: Ayers Andrea J.
-
Form D Manhattan Crossing Allia
-
Form 4 STANLEY BLACK & DECKER, For: Mar 15 Filed by: CARTER SUSAN K
-
Form 8-K CALERES INC For: Mar 19
-
Form 4 STANLEY BLACK & DECKER, For: Mar 15 Filed by: Crew Debra Ann
-
Form 6-K British American Tobacco For: Mar 19
-
Form D Artist Cap Cameo a Serie
-
Form 4 STANLEY BLACK & DECKER, For: Mar 15 Filed by: Hankin Michael David
-
Form 6-K BRASKEM SA For: Dec 31
-
Form D GSBackers Auradine Fund